Definium Therapeutics (DFTX) Exchange Rate Effect (2021 - 2026)
Definium Therapeutics (DFTX) posted quarterly Exchange Rate Effect of $3000.0 for Q1 2026, up 125.0% year-over-year from $1333.3 in Q1 2025, and up 200.0% quarter-over-quarter from $1000.0 in Q4 2025.
Powered by 
Analysis
Definium Therapeutics (DFTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Exchange Rate Effect for 6 consecutive years, with $3000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 125.0% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $8000.0 (up 138.1% YoY), while the FY2025 annual figure was -$7000.0, up 76.67% from the prior year.
- Exchange Rate Effect grew to $3000.0 in Q1 2026 per DFTX's latest filing, from $1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $57000.0 in Q2 2023 and bottomed at -$194000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$15529.4 across 5 years, with a median of $1000.0 in 2024.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 240.0% — and 2025, when it soared 2400.0%.
- Definium Therapeutics' Exchange Rate Effect stood at $56000.0 in 2022, then tumbled by 144.64% to -$25000.0 in 2023, then soared by 104.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then surged by 200.0% to $3000.0 in 2026.
- Business Quant data shows DFTX's Exchange Rate Effect at $3000.0 in Q1 2026, $1000.0 in Q4 2025, and -$21000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Definium Therapeutics | 4.23 Bn | 4.23 Bn | - | -1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 57,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 56,000.00 |
| Sep 30, 2022 | -136,000.00 |
| Jun 30, 2022 | -194,000.00 |
| Mar 31, 2022 | -35,000.00 |
| Dec 31, 2021 | -4.79 Mn |
| Sep 30, 2021 | 4.81 Mn |